Skip to main navigation Skip to search Skip to main content

Therapy-related myelodysplastic syndrome in adults with Neurofibromatosis

Research output: Contribution to journalArticlepeer-review

Abstract

Although an increased risk of hematologic malignancies in children with Neurofibromatosis-1 (NF-1) is well established, whether adults with NF-1 have an increased risk of such malignancies is unclear. We currently describe two adult patients with NF-1 who rapidly developed secondary myelodysplastic syndromes with abnormalities of chromosome 7 following chemotherapy for AML. We propose that adults with NF-1 also have abnormalities of hematologic progenitor cells.

Original languageEnglish (US)
Pages (from-to)605-608
Number of pages4
JournalLeukemia and Lymphoma
Volume32
Issue number5-6
DOIs
StatePublished - 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute myelogenous leukemia
  • Adult
  • Myelodysplastic syndrome
  • Neurofibromatosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Therapy-related myelodysplastic syndrome in adults with Neurofibromatosis'. Together they form a unique fingerprint.

Cite this